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The role of the human papillomavirus oncoprotein E7 in carcinogenesis has been extensively studied. While the role of HPV E7 in the
viral life cycle has also been studied, certain disparities exist, indicating that genotype differences may influence the role that E7 plays in the
viral life cycle. In this study, we investigated the role of HPV18 E7 in the viral life cycle in order to gain a further understanding of this issue.
To determine the role that HPV18 E7 plays in the viral life cycle, a translation termination substitution mutant of E7 in the context of the full
HPV18 genome was created. We introduced linearized HPV18 E7-deficient genomic DNA into primary keratinocytes, where it recircularized
and was maintained episomally at a range of five to several hundred copies of HPV genomic DNA. The mutant genomes failed to amplify
following epithelial stratification and differentiation in organotypic culture. Moreover, virion morphogenesis did not occur. We found that the
expression of HPV16 or HPV18 E7 in trans was able to rescue the amplification defect but not the defect in virion morphogenesis. These
studies indicate that HPV18 E7 plays a critical role in the productive stage of the viral life cycle. In addition, these studies add further proof to
the hypothesis that genotype differences exist for the role of E7 during the viral life cycle.
D 2005 Elsevier Inc. All rights reserved.Keywords: Human papillomavirus; Viral life cycle; E7Introduction
Human papillomaviruses (HPV) are small, double-
stranded DNA tumor viruses that infect the squamous
epithelium and induce papillomas. The epitheliotropic
HPVs can be divided into subsets based on their ability to
infect specific anatomic regions. One such subset of HPVs
infects the anogenital region and can be further divided into
low- and high-risk HPVs based on the frequency with which
they induce viral-associated tumors. Low-risk HPVs are
rarely found in malignant tumors but induce benign lesions,
while high-risk HPVs are frequently found associated with0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.04.036
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relationship between HPV infection and cervical cancer is
primarily due to the ability of the viral oncoproteins, E6 and
E7, to abrogate the cell cycle (Huibregtse and Beaudenon,
1996; Jones and Munger, 1996). Perhaps, the most
extensively studied interactions between E6 and E7 and
cellular targets are the ability of E6 to bind to and degrade
p53 (Scheffner et al., 1992) and the ability of E7 to bind to
pRB (Jones and Munger, 1997). While numerous studies
have been performed to understand the role that these
oncoproteins play in carcinogenesis, their role in the
complete viral life cycle remains unclear, as marked
differences appear to exist between the roles of the
oncoproteins from different high-risk HPV types.
The complete life cycle of HPV is tightly linked to the
differentiation program of the host epithelium (Howley,
1996; Meyers et al., 1992, 1997). HPV gains entry to the
mitotically active basal cells through microabrasions in the
epithelium. It is in this layer that the initial phase of the viral005) 61 – 68
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established as a low copy number nuclear plasmid. As the
infected cells begin the normal differentiation program, the
basal cells divide and a daughter cell leaves the basement
membrane to stratify and differentiate. This leads to the start
of the productive viral life cycle, during which the viral
genome is amplified, late genes are expressed, and virions
are produced. HPVs are dependent on the host DNA
replication machinery to synthesize viral DNA. Uninfected
daughter cells typically exit the cell cycle as they begin to
differentiate. In order to replicate their genomes to high
levels prior to encapsidation, HPV-infected cells do not exit
the cell cycle in suprabasal cells. This cell cycle exit block is
believed to be due to the functions of the viral oncoprotein
E7 (Cheng et al., 1995; Demeter et al., 1994).
The organotypic (raft) epithelial culture system has been
used to develop an in vitro system capable of reproducing
the entire viral life cycle (Meyers et al., 1992, 1997). This
system has been used to study the complete life cycle of
HPV31b (Frattini et al., 1996; Meyers et al., 1992; Ozbun
and Meyers, 1997, 1998a, 1998b, 1999a, 1999b), and
infectious stocks of HPV16, HPV18, HPV31b, HPV39,
HPV45, and chimeric HPV18/16 have also been produced
using this system (McLaughlin-Drubin and Meyers, 2004;
McLaughlin-Drubin et al., 2003, 2004; Meyers et al., 1992,
1997, 2002). In this study, we have used this system to
investigate the role that the HPV18 E7 oncoprotein plays in
the complete viral life cycle. We show that HPV18 E7 is
required for amplification of the viral genome upon differ-
entiation of the host tissue and that expression of both
HPV16 and HPV18 E7 in trans is sufficient to rescue
amplification but not infectious virus production.Fig. 1. Southern (DNA) blot hybridization of representative HPV18 wild-
type and HPV18 E7D: 4 cell lines grown in monolayer culture. Cellular
DNA was isolated from cultures approximately 70 days after electro-
poration (passage 4). Five micrograms of total cellular DNAwas separated
by electrophoresis on a 0.8% agarose gel, transferred to a nylon membrane
and hybridized with a 32P-labeled HPV18 genomic probe. (A) HPV18 wild-
type DNA. (B) HPV18 E7D null DNA. Samples in the 0 lanes were
digested with HindIII, which does not digest the HPV18 genome, and
samples in the 1 lanes were digested with EcoRI, which linearizes
HPV18. HPV18 copy number standards are shown. Arrows indicate Form
II DNA (nicked), Form III DNA (linear), and Form I DNA (supercoiled).Results
Extension of HFK lifespan by E7 mutant HPV18
In order to investigate the role of the full length E7
oncoprotein in the life cycle of HPV18 a mutant HPV18
genome was constructed in the context of pBSHPV18.
Early-passage HFKs were transfected with either wild-type
or E7 mutant HPV18. Cells were selected in culture for
extended growth/immortalization. During this time, the
cultures went through crisis, and following the crisis, the
cell lines were expanded. 100% of the twenty each HPV18
wild-type and E7 mutant electroporations displayed an
extended lifespan as compared to the non-transfected
control cells, which started to die approximately 1 month
after electroporation (data not shown). Thus, HPV18 E7 is
not necessary for extension of the lifespan of HFKs. Two of
the HPV18E7 null lines, HPV18E7D:3 and HPV18E7D:4,
were chosen for further growth in culture to determine the
extent of the lifespan extension caused by the HPV18 E7
mutant genome. Both lines have been growing for more
than a year and a half in culture and continue to grow well.Thus, we conclude that HPV18E7 is not necessary for
immortalization of HFKs.
Episomal maintenance of E7 mutant HPV18 genomes
We next investigated whether E7 was necessary for
stable maintenance and replication of the HPV18 genome
during the non-productive stage of the viral life cycle. Total
DNA was isolated from the HPV18 wild-type and E7
mutant cell lines after several weeks of growth in culture.
While the presence of the wild-type HPV18 genome was
confirmed by Southern blot, the HPV18 E7 mutant genomes
were absent, even though we are able to detect as little as
one HPV genome copy per cell (data not shown). The
HPV18 E7 mutant lines were allowed to grow for
approximately 70 days total in culture (corresponding to
passage four in culture) before they were re-analyzed by
Southern blot. Total DNA was isolated and digested with
HindIII, which does not digest the HPV18 genome, and
EcoRI, which linearizes the genome. The digested DNA
was Southern blotted and probed with an HPV18 genomic
probe (Fig. 1). Forms II and I DNA are present in the 0
lane, indicating that the genome is episomal. Additionally,
we were unable to detect the presence of integrated DNA,
which would have been manifested as a band migrating
above the form II DNA near the agarose gel well on the
Southern blot. A comparison of the linear DNA in the 1
lane to the HPV18 copy number controls reveals that the
genome in this representative line is being maintained at
greater than 100 copies/cell (Fig. 1). Overall, the mutant
genome was maintained at approximately five to several
hundred copies per cell in the lines studied (data not shown).
Fig. 2. Hematoxylin and eosin and involucrin staining of HFK, HPV18
wild-type and HPV18 E7D:4 raft tissue. (A–B) HFK raft tissue. (C–D)
HPV18 wild-type raft tissue. (E–F) HPV18 E7 null raft tissue (from
passage 12 cells). (A, C, E) Hematoxylin and eosin staining. (B, D, F)
Involucrin staining (20 magnification).
Fig. 3. Southern (DNA) blot hybridization of HPV18 E7D:4 cell line grown
in monolayer and raft culture. Five micrograms of total cellular DNA was
separated by electrophoresis on an 0.8% agarose gel, transferred to a nylon
membrane and hybridized with a 32P-labeled HPV18 genomic probe. (A)
HPV18 wild-type DNA from monolayer (mono) and 12-day raft cultures.
(B) HPV18 E7 null DNA from passage 12 monolayer cultures (mono) and
4- and 12-day raft cultures (also from passage 12 cells). Samples in the 0
lanes were digested with HindIII, which does not digest the HPV18
genome, and samples in the 1 lanes were digested with EcoRI, which
linearizes HPV18. HPV18 copy number standards are shown. Arrows
indicate Form II DNA (nicked), Form III DNA (linear), and Form I
(supercoiled).
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wild-type HPV18 (data not shown). These results demon-
strate that E7 is not needed for HPV18 DNA synthesis in the
non-productive stage of the viral life cycle, however,
HPV18 E7 null genomes begin replicating their genomes
considerably slower than wild-type HPV18.
Morphology of HPV18E7 null cell lines grown in raft
cultures
We were interested in examining the effect of the loss of
HPV18 E7 on tissue differentiation and morphology, as the
life cycle of HPV is tightly linked to the differentiation
program of the host tissue. While HPVs do affect the
expression of keratinocytes differentiation markers, we do
not see an evidence of this at the early stages, similar to our
previous studies (McLaughlin-Drubin et al., 2003). Several
HPV18 E7 null lines were allowed to stratify and differ-
entiate in the raft culture system, and tissue sections were
stained with hematoxylin and eosin to observe tissue
morphology. Representative data from the HPV18E7D:4
line can be seen in Fig. 2. Occasional koilocytes and periodic
parakeratotic bodies, and a normal looking cornified layer
could be observed (Fig. 2). Overall, the mutant raft cultures
differentiated similarly to wild-type HPV18 raft cultures
(Fig. 2) indicating that the loss of HPV18 E7 did not affect
the ability of the tissue to differentiate.
Amplification of HPV18 E7 mutant genomes upon growth in
raft culture
We next analyzed the ability of the HPV18 E7 null cell
lines to complete the viral life cycle. Prior to encapsidation,the HPV genome is amplified in differentiating squamous
epithelium. To investigate DNA amplification, HPV18 E7
null raft cultures were grown and total DNA was harvested.
DNA samples were digested with either HindIII, which does
not digest the HPV18 genome, or EcoRI, which linearizes
the genome, and analyzed by Southern blot. Fig. 3 shows
that the viral genome decreased in amount upon growth in
raft culture. Thus, HPV18E7 is essential for HPV18 DNA
amplification.
Infectious HPV18 E7 mutant biosynthesis
Amplification of the viral genome is a necessary step in
the viral life cycle that must occur prior to infectious virus
production. We suspected that infectious HPV18 E7 mutant
virus is not produced, as amplification of the HPV18 E7
mutant genome does not occur upon differentiation of the
raft culture tissue. HPV18E7D:3 and HPV18E7D:4 raft
cultures were grown and putative viral stocks were prepared
as described previously (McLaughlin-Drubin et al., 2003,
2004; Meyers et al., 1997, 2002). The HPV18 infectivity
studies were based on an in vitro system described by Smith
et al (McLaughlin-Drubin et al., 2003, 2004; Smith et al.,
1995). HaCaT cells were infected with a 1:100 dilution of
the putative viral stock and were harvested 48 h post-
infection. The HPV18 spliced E1^E4 transcript represented
by a nested PCR product of approximately 226 bp can be
seen in the HPV18 wild type sample. The absence of the
HPV18 spliced E1^E4 transcript in the HPV18 E7 mutant
samples indicates that the putative HPV18 E7 mutant viral
Fig. 4. Infectious titer of HPV18 cell lines. Shown is a 2% agarose gel of
nested RT-PCR-amplified HPV18 E1^E4 and h-actin. Lane 1, negative
control (no virus). Lane 2, positive control (HPV18WT). Lane 3,
HPV18E7D. Lane 4, HPV18E7D infected with lxsn retroviral control.
Lane 5, HPV18E7D infected with HPV16E7 retrovirus. Lane 6,
HPV18E7D infected with HPV18E7 retrovirus. h-actin and HPV18
E1^E4 are indicated in the right and molecular size markers are indicated
in the left. All mutant putative viral stocks were obtained from raft cultures
made from passage 12 cells.
Fig. 6. Southern (DNA) blot hybridization of HPV18 E7 retrovirus-infected
HPV18 E7D:4 cell line grown in monolayer and raft culture. Five
micrograms of total cellular DNA from 4-, 8-, and 12-day raft cultures
was separated by electrophoresis on an 0.8% agarose gel, transferred to a
nylon membrane and hybridized with a 32P-labeled HPV18 genomic probe.
Samples in the 0 lanes were digested with HindIII, which does not digest
the HPV18 genome, and samples in the 1 lanes were digested with
EcoRI, which linearizes HPV18. HPV18 copy number standards are
shown. Arrows indicate Form II DNA (nicked) and Form II DNA (linear).
All mutant raft cultures were made with passage 12 cells.
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make infectious virus (Fig. 4).
trans complementation of the HPV18 E7 null amplification
defect by HPV16 E7 and HPV18 E7
In order to verify that the null mutation was responsible
for the phenotypes observed, we next wished to reintroduce
the wild-type E7 gene and to test if the reintroduction
reverses the effects observed with the null mutant. In order
to investigate this, we wished to determine if the expression
of either HPV18 E7 or HPV16 E7 could complement the
amplification defect in trans. In addition to verifying that
the amplification defect was due to the loss of E7, these
studies would address the type-specific nature of the role of
E7 in the HPV18 viral life cycle. The HPV18E7D:4 line was
infected with 10 cfu/ml of HPV18E7 or HPV16E7 retro-
virus. Following selection with G418 to ensure that the cells
contained the E7 retrovirus, the cells were allowed to
stratify and differentiate in the raft culture system, and tissue
sections were stained with hematoxylin and eosin to observe
tissue morphology. Overall, infection with the HPV16 and
HPV18 E7 retroviruses did not affect the ability of the tissue
to stratify and differentiate (Fig. 5).
We next analyzed the ability of HPV16 and HPV18 E7 to
rescue the amplification defect seen in the HPV18 E7 nullFig. 5. Hematoxylin and eosin staining of HPV18E7D:4 raft tissues. Panels A–C,
E7 null raft tissues. Panels B and E, HPV18 E7 null + HPV16 E7 retrovirus raft tiss
mutant raft cultures were made with passage 12 cells.cell lines. Uninfected, HPV16 E7-, and HPV18 E7-infected
HPV18 E7 null raft cultures were grown and total DNAwas
harvested. DNA samples were digested with either HindIII,
which does not digest the HPV18 genome, or EcoRI, which
linearizes the genome, and analyzed by Southern blot (Fig.
6). The uninfected HPV18 E7 null genome did not amplify
while the retrovirus-infected HPV18 E7 null genome did
amplify (Fig. 6). Thus, the amplification defect seen in the
HPV18E7 null lines is, in fact, due to the loss of E7, and this
defect can also be complemented in trans by HPV16 E7
(data not shown).
We next investigated the effect of expressing HPV16 E7
and HPV18 E7 in trans on the ability of the mutant
genomes to produce infectious virus. Unlike its effect on
amplification, the trans expression of HPV16 E7 and
HPV18 E7 did not rescue the infectivity defect seen in the
HPV18 E7 mutant genomes (Fig. 4).Discussion
In this study, we have examined the role of the HPV18
oncoprotein E7 in the complete viral life cycle. Although
HPV18 E7 mutant genomes were not detectable by South-
ern blot as early as were wild type HPV18 genomes, the
introduction of HPV18 E7 mutant genomes did extend the5-day raft tissues. Panels D–F, 10-day raft tissues. Panels A and D, HPV18
ues. Panels C and F, HPV18 E7 null + HPV18 E7 retrovirus raft tissues. All
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Moreover, the genomes in these cells were maintained
episomally, indicating that HPV18 E7 does not play a major
role in the non-productive stage of the viral life cycle. In
contrast, we determined that HPV18 E7 plays a key role in
the productive stage of the HPV18 life cycle. Although the
morphology of raft cultures of HFKs containing HPV18 E7
mutant genomes appeared similar to raft cultures containing
wild type genomes, genomes lacking E7 were unable to
amplify upon differentiation of the host tissue and to
produce infectious virus. Finally, by expressing both
HPV16 and HPV18 E7 in trans, we were able to rescue
the defect in amplification but were unable to rescue the
defect in virus production.
The methodology used in this study to introduce HPV
genomes into keratinocytes utilizes immortalization as
selection rather than the addition of a selection marker.
The reason that HPV18 E7 mutant genomes were not
detectable by Southern blot as early as HPV18 wild type
genomes is therefore unlikely due to differences in selective
advantage for growth over control cells, as cells that are not
immortalized will die when the control cells die. Although
there is no selective advantage for growth, E7 does affect
genome replication. We have previously shown that a 3-
week lag period exists between electroporation of HPV18
genomes into keratinocytes and subsequent recircularization
and detection by Southern blot (McLaughlin-Drubin and
Meyers). This lag period is almost double for HPV31, 39,
and 45 (McLaughlin-Drubin and Meyers, 2004). Thus, we
hypothesize that E7 plays a role in the kinetics of
recircularization and establishment of the HPV genome,
and that differences in the speed at which this occurs exist
between HPV types.
The observation that HPV18 E7 mutant genomes
extended the lifespan of HFKs is in sharp contrast to
previous findings in the literature. It has been shown that
HPV16 E7 and HPV31a E7 mutant genomes were incapable
of extending the lifespan of primary HFKS (Flores et al.,
2000; Thomas et al., 1999). One explanation for this finding
could be differences in the protocols used in our studies as
compared to those used in previous studies. We performed
experiments with HPV31 E7 mutant genomes in a manner
similar to those presented in this paper and obtained results
consistent with the previously published results (Thomas et
al., 1999). Therefore, we hypothesize that the differences
observed are due to genotype-specific differences in the
requirement for E7 in the extension of the lifespan of HFKs.
A comparison of these and previous studies indicate that
other genotype-specific differences in the requirement for
E7 in the viral life cycle also exist. While HPV31 E7 mutant
genomes are unable to replicate as stable episomes in
primary HFKs (Thomas et al., 1999), studies on HPV16 E7
mutant genomes in the immortalized HFK cell line, BC-1-
Ep/SL, showed that HPV16 E7 mutant genomes are able to
replicate as stable episomes (Flores et al., 2000). This
finding is similar to our finding that HPV18 E7 mutantgenomes are able to replicate as stable episomes in primary
HFKs. A closer look at both the phylogenetic relationship
between the virus types and their correlation to disease risk
may shed light on these differences. Interestingly, both
HPV16- and HPV31 E7-deficient genomes, which are
unable to extend the lifespan of HFKs (Flores et al., 2000;
Thomas et al., 1999), belong to phylogenetic group A. On
the other hand, HPV18 E7-deficient genomes, which belong
to group C, are able to extend the lifespan of HFKs. We
speculate that another portion of the HPV18 genome is
capable of extending the lifespan of HFKS and this
particular function may be missing in HPV16 and HPV31.
It would be interesting to perform similar studies with
HPV39- and HPV45-deficient genomes, as these virus types
also belong to group C. In addition to a possible link
between E7 function and phylogenetic relationship, a
possible link between E7 function in the viral life cycle
and disease risk also exists. HPV31 is typically considered a
mid-risk HPV and HPV31 E7-deficient genomes are not
maintained episomally (Thomas et al.), while the high-risk
HPV16 (Flores et al., 2000) and HPV18 E7-deficient
genomes are maintained episomally. Support for this
hypothesis lies in studies of the role of the low-risk
HPV11 E7 during the viral life cycle, which showed that
HPV11 E7-deficient genomes cannot be maintained episo-
mally after passaging of the cells (Oh et al., 2004).
Therefore, it appears that the role of E7 in maintaining
viral episomes may be linked to disease correlation.
Previous studies have shown that the E6–E7 region of
HPV18 was capable of immortalizing HFKs (Hudson et al.,
1990). In addition, while E7 alone was capable of immortal-
izing the cells at a low frequency, E6 alone had no effect
(Hudson et al., 1990). Thus, we were surprised to find that
our HPV18 E7 null cell lines, which contained E6, were
capable of continued growth in culture, indicating that the
cells were indeed immortalized. It must be noted, however,
that the earlier experiments on the immortalization capa-
bilities of E6 and E7 were done by overexpressing E6 and
E7 in isolation (Hudson et al., 1990), providing only a
limited understanding of the function of the oncoproteins.
Our studies were performed using the entire HPV genome
containing a mutation in the E7 ORF, providing a much
clearer picture of the role of the oncoproteins in the
complete viral life cycle.
The introduction of HPV18 E7 rescued the amplifica-
tion defect seen in the HPV18 E7-deficient cell lines,
indicating that the amplification defect was indeed due to
the lack of E7. Intriguingly, the introduction of HPV16
E7 also rescued this defect. On the other hand, the
introduction of either HPV16 E7 or HPV18 E7 did not
rescue the ability to produce infectious virus. It is
possible that E7 is required early during the production
of cells lines to establish a cellular environment that will
be capable of infectious virus production. In addition, it
is also possible that the mutation in E7 may affect cis
elements involved in splicing or late gene expression via
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null mutations will be necessary to address this issue.
These data shed light on the genotype-specific nature of
the requirement for E7 during the life cycle of HPV. In
addition, the ability to infect the HPV18 E7 null cell line
with E7 expressing retroviruses lays the foundation for a
powerful system to study the role of E7 in the viral life
cycle. Specifically, E7 retroviruses containing mutations
in particular functions of E7 can be used to dissect
exactly which features of the oncoprotein are needed
during the productive stage of the viral life cycle.Materials and methods
Plasmids and constructs
pBSHPV18 (a generous gift from H. zur Hausen)
contains the HPV18 genome inserted into the EcoRI site
of pBS. A translation termination mutant of E7 of HPV18
was constructed via the QuikChange XL Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). Three stop
codons (ochre) were engineered at amino acids nine through
eleven.
Keratinocyte and organotypic raft cultures
Primary human foreskin keratinocytes (HFK) were
isolated from newborn circumcision as described previously
(McLaughlin-Drubin et al., 2003). Keratinocytes were
grown in 154 medium (Cascade Biologics, Inc., Portland,
OR) supplemented with Human Keratinocyte Growth
Supplement Kit (Cascade Biologics, Inc.). Keratinocyte
lines stably maintaining HPV DNA following electropora-
tion were grown in monolayer culture using E medium in
the presence of mitomycin C treated J2 3T3 feeder cells
(Meyers, 1996; Meyers et al., 1992, 1997).
Organotypic (raft) cultures were grown as previously
described (Meyers, 1996; Meyers et al., 1992, 1997).
Briefly, cell lines were seeded onto rat tail type 1
collagen matrices containing J2 3T3 feeder cells. Follow-
ing cell attachment and growth to confluence, the
matrices were lifted onto stainless steel grids. Once at
the air– liquid interface the raft cultures were fed by
diffusion from below with E medium supplemented with
10 AM 1,2-dioctanoyl-sn-glycerol (C8:O; Sigma Chemical
Co.). Raft cultures were allowed to stratify and differ-
entiate for 10 days, as viral gene expression has been
shown to peak between 10 and 12 days in the raft
system (Ozbun and Meyers, 1997).
Electroporation of primary keratinocytes
Primary human foreskin keratinocytes were electropo-
rated as previously described (Meyers et al., 1997, 2002).
Briefly, pBSHPV18 and pBSHPV18E7D plasmid DNAwere digested with EcoRI, linearizing the viral DNA in E1
and separating it from vector sequences. 10 Al of the EcoRI-
digested DNA (1 Ag/Al) was mixed with 4.25 Al of sonicated
and denatured salmon sperm DNA (10 Ag/Al) in a 1.5-ml
Eppendorf tube. 5106 keratinocytes in a volume of 250 Al
of E medium containing 10% fetal bovine serum (FBS) and
5 mM N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid
were added to the DNA mixture. The DNA and keratinocyte
solution was transferred to an electroporation cuvette and
electroporated using a Gene Pulser (Bio-Rad Laboratories,
Hercules, CA) set at 210 V and 960 AF. The electroporated
cell solution was then layered into 10 ml of E medium
containing 10% FBS and centrifuged at 25  g for 10 min.
The medium was removed and the cell pellets were
resuspended in E medium containing 10% FBS. The
suspensions were then added to 10-cm tissue culture plates
containing mitomycin C-treated J2 3T3 feeder cells. 5 ng of
EGF/ml was added to the culture medium the next day. The
cultures were fed every other day for 7 days with E medium
containing 10% FBS and 5 ng EGF/ml. After the 7-day
period, the cells were fed with E medium containing 5%
FBS and 5 ng EGF/ml until the keratinocytes grew to
confluence, at which time the EGF was omitted from the
medium.
Southern (DNA) blot hybridization
Total cellular DNA was isolated as previously described
(Meyers et al., 1992; Ozbun and Meyers, 1998a). 5 Ag of
total cellular DNA was digested with HindIII, which does
not digest the HPV18 genome or EcoRI, which linearizes
the genome. The samples were then separated by 0.8%
agarose gel electrophoresis and transferred onto GeneScreen
Plus membrane (New England Nuclear Research Products,
Boston, MA) as previously described (Ozbun and Meyers,
1998a). Hybridization of the Southern blot was performed
as previously described (Meyers et al., 1992; Ozbun and
Meyers, 1998a), probing with an HPV18 complete genomic
probe.
Histochemical analyses
Raft cultures were grown for 12 days, harvested, fixed in
10% neutral-buffered formalin, and embedded in paraffin. 4
Am sections were cut and stained with hematoxylin and
eosin as previously described (Meyers et al., 1992).
Retroviral propagation, tittering, and infection
Recombinant retroviruses were generated using the pCL
vector system (Naviaux et al., 1996). Recombinant retro-
viral stocks were generated in RAT-1 cells as described
(Naviaux et al., 1996). HPV18 E7 null cell lines were
infected with 10 cfu/ml of recombinant retrovirus for 2 h.
Cells were selected with 500 Ag of G418 per ml beginning
48 h after infection. Selection lasted 3 to 4 days and was
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cells were grown to confluence and seeded onto collagen
matrices for growth in raft culture.
Virus isolation and in vitro infectivity assay
Virions were isolated as previously described (Meyers et
al., 1997, 2002). The HPV18 infectivity studies were based
on an in vitro system described by Smith et al (Smith et al.,
1995). HaCaT cells, an immortalized human keratinocyte
cell line (kindly provided by Norbert Fusenig), were grown
to confluence in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, 2 mM
glutamine, 1 mM pyruvate, 100 units/ml penicillin and
100 Ag/ml streptomycin in 24 well plates. The wild type and
mutant HPV18 virus stocks were sonicated for 30 s on ice
and then serially diluted with cell culture medium. The
medium was aspirated from the HaCaT cells and 0.5 ml of
each dilution of virus stock was added per well. One well on
each plate received 0.5 ml of medium without virus as a
control. The cells were incubated with the virus for 48 h at
37 -C.
The ability of the wild type and mutant HPV18 viruses to
infect the HaCaT cells after 48 h of incubation was
determined by the presence of the spliced HPV18 E1^E4
mRNA species (Smith et al., 1995). mRNA was purified
from the infected cells using the mRNA capture kit (Roche
Molecular Biochemicals, Indianapolis, IN). Briefly, the
medium was aspirated from the cells and the cells were
washed two times with 0.5-ml ice cold 1 PBS. The final
PBS wash was aspirated from the cells and 0.25-ml lysis
buffer was added to each well. The cell lysates were
removed from the wells and sonicated for 2 min in a cup
horn sonicator on ice. 4 Al of 1:20 diluted biotinylated oligo
dT was added to each lysate. The samples were incubated
for 10 min at 42 -C. 50 Al of the lysate was transferred to a
streptavidin-coated PCR tube and incubated for three min at
37 -C. The RNA captured in the tubes was washed three
times with 200 ml of wash buffer and subsequently used in a
RT reaction utilizing reagents from the First Strand cDNA
kit (Roche Molecular Biochemicals). The cDNA was then
used for nested PCR to detect the HPV18 E1^E4 cDNA.
Forty cycles of PCR was performed on the cDNA using 5V
GTTGTGTATGTGTTGTAAGTGTGA 3V as the forward
primer (located at nucleotide position 772–795 in the
HPV18 genome) and 5VGTCCACAATGCTGCTTCTCCG
3V(located at nucleotide 3580–3600 in the HPV18 genome)
as the reverse primer. 10% of the first PCR mixture was
used as template for 40 cycles of nested amplification
utilizing 5V GAATTGGCTAGTAGTAGAAAGCT 3V
(located at nucleotide position 801–824 in the HPV18
genome) as the forward nested primer and 5V TCCC-
ACGTGTCCAGGTCGTGT 3V (located at nucleotide posi-
tion 3555–3575 in the HPV18 genome) as the reverse
nested primer. An additional set of primers specific for h-
actin was included in the PCR mixture as a control formRNA detection. The forward primer for the first reaction
was 5V GAACCCCAAGGCCAACCGCGA 3V and the
reverse primer was 5V CCACACAGAGTACTTGCGCT-
CAGG 3V. The forward primer for the nested reaction was
5VGATGACCCAGATCATGTTTG 3Vand the reverse primer
was 5V GGAGCATGATCTTGATCTTC 3V. All PCR reac-
tions contained 10 mM Tris–HCl, pH 8.3, 50 mM KCl,
2.5 mM MgCl2, 200 AM dNTPs, 125 ng of each forward
and reverse primer, and 2.5 units of Taq polymerase (Fisher
Scientific). The temperature profile for the first reaction was
95 -C for 5 min, followed by 40 cycles of 95 -C for 30 s,
60 -C for 30 s, 72 -C for 1 min with a final 10 min
extension at 72 -C. The temperature profile for the second
reaction was 95 -C for 5 min, followed by 40 cycles of
95 -C for 30 s, 60 -C for 30 s, 72 -C for 30 s with a final 10
min extension at 72 -C. All PCR products were visualized
by electrophoresis in a 2% agarose-ethidium bromide gel.Acknowledgments
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